Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency

Author： Gonzalez F.J.   Fernandez-Salguero P.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.16, Iss.10, 1995-10, pp. : 325-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetic Syndrome of Dihydropyrimidine Dehydrogenase Deficiency

By  

Current Pharmacogenomics, Vol. 5, Iss. 1, 2007-03 ,pp. : 31-38

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Dihydropyrimidine Dehydrogenase Deficiency on Outcomes with Fluorouracil

By Gardiner S.J.  

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 21, Iss. 1-2, 2002-01 ,pp. : 1-16

Adis International

Access to resources Recommend Favorite

Capecitabine: Severe toxicity and death in a patient with dihydropyrimidine dehydrogenase deficiency: case report

By  

Reactions Weekly, Vol. 1, Iss. 1174, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Fluorouracil: Intestinal disorders in a patient with dihydropyrimidine dehydrogenase deficiency: case report

By  

Reactions Weekly, Vol. 1, Iss. 1420, 2012-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Pharmacogenetics and Metabolism from Science to Implementation in Clinical Practice: The Example of Dihydropyrimidine Dehydrogenase

By  

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2028-2034

Bentham Science Publishers

Access to resources Recommend Favorite